GSK receives KFDA approval for Rotarix vaccine for Rotavirus

Published: 2008-03-19 06:56:00

Updated: 2008-03-19 06:56:00

GlaxoSmithKline says it has received the Korea Food and Drug Administration approval to market Rotarix vaccine given to children for the prevention of gastroenteritis caused by rotavirus.

The rotavirus vaccine is a live- attenuated vaccine licensed in 99 countries around the world. The vaccine...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK